Purchase Order 75N93018P00777

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Qlucore Inc. for $13,738.00 on August 23, 2019. The order, firm fixed price with no set-aside, covers Qlucore Omics Explorer software. Performance is located in New York, New York, with completion by August 31, 2020. The purchase order funds software licensing for research and data analysis purposes.</p>

This is a firm fixed-price purchase order award from the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Qlucore Inc., a foreign-owned, for-profit corporation. The award is for an academic floating license of Qlucore's Omics Explorer software, a data analysis tool used in research on fields such as genomics, cancer, infectious diseases, and aging. The contract has a ceiling value of $5,549.00 and an...

The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $43,587.50 firm fixed price purchase order to Qiagen, LLC for one catalog item #834083, HGMD Data Download for clinical use by a medium-sized enterprise. The place of performance will be Qiagen's Germantown, Maryland division. The period of performance is January 1, 2024 through November 25, 2024. No set aside designation or subcontractors were indicated....

The National Institute of Allergy and Infectious Diseases awarded a purchase order to Qiagen, LLC for $13,936.20 in QIAcube-compatible QIAseq sequencing kits on September 13, 2021, with ultimate completion on July 7, 2022. The order was issued to de-obligate unexpiring fiscal year 2021 funds in accordance with 31 U.S.C. Section 1552(a) ahead of the September 30, 2026 period-of-availability close. Performance takes place in Germantown, Maryland. The purchase order carries firm fixed price pricing...

The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $43,587.50 firm fixed price purchase order to Qiagen, LLC. Qiagen will perform under the contract from its place of performance in Germantown, Maryland between December 20, 2023 and November 25, 2024. The description indicates Qiagen will provide products or services under contract number AMBIS #2196972 in support of NIH/NIAID programs, though specifics of the...

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Life Technologies Corporation for $19,760.00 on June 21, 2019, with ultimate completion on July 21, 2019. Place of performance is Bethesda, Maryland. The order covers laboratory supplies and consumables, priced on a firm fixed price basis with no set-aside designation.</p>

The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $14,722.93 firm fixed price purchase order to AB Sciex LLC for total service coverage for a PA 800 Plus CGE instrument. The place of performance will be AB Sciex LLC's Redwood City, California facility. The period of performance is one year, starting on February 19, 2024 through February 18, 2025. No set aside designation or subcontractors were indicated....

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Qiagen, LLC for $12,928.46 on August 15, 2017, for RNA kits, beads, and processor equipment on a firm fixed price basis. Work is performed in Hamilton, Montana, with an ultimate completion date of September 1, 2017.</p>

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Molecular Devices LLC on July 29, 2019, for $48,522.00 in consumables on a firm fixed-price basis. Place of performance is San Jose, California. The order completed on August 28, 2019. The pre-solicitation was posted July 15, 2019, with a due date of July 25, 2019.</p>

The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a purchase order to Qiagen, LLC for IPA software licenses. The contract is a firm fixed-price agreement with a potential value of $108,948.00 and a period of performance from February 1, 2018 to January 31, 2019. No set-aside designation was used. Qiagen, LLC is a division of Qiagen N.V., an international provider of sample and assay technologies that has...